University of Oklahoma
Oklahoma City, Oklahoma, 73117, United States
Location status: Recruiting
Location contact
Camila Bonin Pinto, PhD
PRINCIPAL_INVESTIGATOR
Cheryl Adams, RN
CONTACT
Faddi Saleh Velez, MD
SUB_INVESTIGATOR
NCT Number: NCT06516588
This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).
Interested in participating?
Request Info18 year–99 year
All sexes
Interventional
Phase 2
Oklahoma City, Oklahoma, 73117, United States
Location status: Recruiting
Camila Bonin Pinto, PhD
PRINCIPAL_INVESTIGATOR
Cheryl Adams, RN
CONTACT
Faddi Saleh Velez, MD
SUB_INVESTIGATOR
The goal of this study is to learn important information about the effects of electrical stimulation (Transcranial direct current stimulation (tDCS) on brain functioning in those with post-stroke cognitive impairment (PSCI). The findings will help determine how stimulation affects the brain's activity, cerebral blood flow, and circulating blood biomarkers of neuroinflammation after stroke. The study will use different forms of non-invasive brain imaging to see whether stimulation changes how the brain responds during a memory task. Functional near-infrared spectroscopy (fNIRS) and electroencephalograph (EEG) will be used, we will also collect blood samples for the biomarkers of inflammation. The study also uses cognitive tests and questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
tDCS will deliver direct current through rubber electrodes in saline-soaked sponges. Device sends a low-level current from the positive electrode, the anode, to the negative electrode, the cathode. Direct current will be transferred by a saline-soaked pair of surface sponge electrodes (35cm2) and delivered by a specially developed, battery-driven, constant current stimulator with a maximum output of 10mA. The anode will be placed over the LDLPFC and the cathode over the contralateral supra-orbital area.
Other names: tDCS
Time frame: Changes from baseline after intervention week (two weeks), one and three months
It is a 30-point test about several cognitive domains (visuospatial/executive, naming, memory, attention, language, abstraction, delayed recall and orientation) and a screening tool used of MCI and dementia.
Time frame: Changes from baseline after one and three months
NIH Toolbox tests is a computarize test that acess fluid abilities (i.e., working memory, processing speed, episodic memory, and two aspects of executive functioning) and crystallized abilities (i.e., dependent upon past learning and experience), resulting in Standard Scores for these superordinate categories, as well as a total Composite score of all tests.These norms were previously reported to align with the age-corrected normative data for the traditional neuropsychological measures.
Time frame: Changes on fNIRS signal from baseline after after intervention week (two weeks), one and three months
fNIRS signal will be recorded using the 16-source/16-detector system (NIRSport, NIRx)
Time frame: Changes on EEG signal from baseline after after intervention week (two weeks), one and three months
EEG signal will be recorded at 1 kHz using a 16-channel system (HIAMP,g.tec).
Time frame: Changes on maximal arteriolar dilation and mean maximal venular dilation from baseline after intervention week (two weeks), one and three months
DVA signal ill be recorded as the mean maximal arteriolar dilation and mean maximal venular dilation in response to flicker light stimulation.
Time frame: Changes on blood marker levels from baseline after intervention week (two weeks), one and three months
Bblood draw via venipuncture and collect up to 40mL of blood for each visit. We will separate set of plasma (for study 4), serum samples, whole blood, and blood cells (including white blood cells) , a set of each will be stored for future analyses.
Contact information is provided by the study sponsor or research team.
Camila Bonin Pinto, PhD
CONTACT
Cheryl Adams, RN
CONTACT
University of Oklahoma
Other
Post-Stroke Cognitive Impairment: Neurovascular Mechanisms and Non-Invasive Brain Stimulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05826548
Basal Ganglia Diseases, Brain Diseases
Lido, Venezia, Italy
View Trial DetailsNCT02670161
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Evanston, Illinois, United States
View Trial DetailsNCT06534164
Behavior, Brain Diseases
Freiberg, Germany
View Trial DetailsNCT05826626
Brain Diseases, Cardiovascular Diseases
Lido, Venezia, Italy
View Trial Details